Loading...
Pacira BioSciences, Inc.
PCRX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$22.55
$0.73(3.35%)
Pacira BioSciences, Inc. (PCRX) Financial Performance & Income Statement Overview
Review Pacira BioSciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.85%
↑ 3.85%
Operating Income Growth
-183.69%
↓ 183.69%
Net Income Growth
-337.30%
↓ 337.30%
Operating Cash Flow Growth
22.46%
↑ 22.46%
Operating Margin
-11.65%
↓ 11.65%
Gross Margin
73.54%
↑ 73.54%
Net Profit Margin
-14.76%
↓ 14.76%
ROE
-12.94%
↓ 12.94%
ROIC
-6.44%
↓ 6.44%
Pacira BioSciences, Inc. (PCRX) Income Statement & Financial Overview
Review Pacira BioSciences, Inc.'s (PCRX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $187.25M | $168.57M | $178.02M | $167.12M |
| Cost of Revenue | $39.89M | $38.86M | $58.58M | $61.74M |
| Gross Profit | $147.37M | $129.71M | $119.44M | $105.38M |
| Gross Profit Ratio | $0.79 | $0.77 | $0.67 | $0.63 |
| R&D Expenses | $23.90M | $19.10M | $20.34M | $18.24M |
| SG&A Expenses | $79.61M | $74.33M | $68.13M | $72.03M |
| Operating Expenses | $122.66M | $269.24M | $88.46M | $90.26M |
| Total Costs & Expenses | $162.55M | $308.10M | $147.05M | $152.002M |
| Interest Income | $5.55M | $5.48M | $4.75M | $3.90M |
| Interest Expense | $4.68M | $3.85M | $3.12M | $2.63M |
| Depreciation & Amortization | $21.24M | $20.25M | $18.86M | $18.43M |
| EBITDA | $50.60M | -$114.75M | $49.84M | $35.38M |
| EBITDA Ratio | $0.27 | -$0.68 | $0.28 | $0.21 |
| Operating Income | $24.70M | -$139.53M | $30.98M | $15.12M |
| Operating Income Ratio | $0.13 | -$0.83 | $0.17 | $0.09 |
| Other Income/Expenses (Net) | $822000.00 | $671000.00 | $8.34M | -$1.48M |
| Income Before Tax | $25.53M | -$138.86M | $36.58M | $13.64M |
| Income Before Tax Ratio | $0.14 | -$0.82 | $0.21 | $0.08 |
| Income Tax Expense | $9.48M | $4.61M | $17.70M | $4.66M |
| Net Income | $16.04M | -$143.47M | $18.89M | $8.98M |
| Net Income Ratio | $0.09 | -$0.85 | $0.11 | $0.05 |
| EPS | $0.35 | -$3.11 | $0.41 | $0.19 |
| Diluted EPS | $0.35 | -$3.11 | $0.39 | $0.19 |
| Weighted Avg Shares Outstanding | $46.19M | $46.13M | $46.17M | $46.50M |
| Weighted Avg Shares Outstanding (Diluted) | $49.04M | $46.13M | $50.54M | $52.19M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan